2022
DKA Prevention and Insulin Pumps: Lessons Learned From a Large Pediatric Pump Practice
Doyle EA, Weinzimer SA, Tamborlane W. DKA Prevention and Insulin Pumps: Lessons Learned From a Large Pediatric Pump Practice. The Science Of Diabetes Self-Management And Care 2022, 48: 476-482. PMID: 36129121, DOI: 10.1177/26350106221125699.Peer-Reviewed Original ResearchConceptsContinuous glucose monitorHigher A1C levelsA1c levelsDKA eventsInsulin pumpPump usersPump-treated patientsRetrospective chart reviewPediatric endocrinology practiceType 1 diabetesInsulin pump usersConcurrent illnessDKA preventionPump patientsDiabetes durationDKA episodesMean A1CChart reviewEndocrinology practiceDKA ratesDKA severityMean ageInsulin omissionMost episodesPatientsCongenital hyperinsulinism in infancy and childhood: challenges, unmet needs and the perspective of patients and families
Banerjee I, Raskin J, Arnoux JB, De Leon DD, Weinzimer SA, Hammer M, Kendall DM, Thornton PS. Congenital hyperinsulinism in infancy and childhood: challenges, unmet needs and the perspective of patients and families. Orphanet Journal Of Rare Diseases 2022, 17: 61. PMID: 35183224, PMCID: PMC8858501, DOI: 10.1186/s13023-022-02214-y.Peer-Reviewed Original ResearchConceptsBlood glucose monitoringBetter outcomesUnmet needGlucose monitoringLimited treatment optionsLong-term developmental outcomesPerspectives of patientsCare of newbornsKey clinical challengeAdverse eventsSignificant morbidityPersistent hypoglycemiaTreatment optionsNeurological damageSpecialized careSpecialized centersCommon causeCurrent treatmentClinical challengeCongenital hyperinsulinismEarly diagnosisEffective treatmentNeurocognitive impairmentNew therapiesPatients
2021
Evaluation of Web-Based and In-Person Methods to Recruit Adults With Type 1 Diabetes for a Mobile Exercise Intervention: Prospective Observational Study
Ash GI, Griggs S, Nally LM, Stults-Kolehmainen M, Jeon S, Brandt C, Gulanski BI, Spanakis EK, Baker JS, Whittemore R, Weinzimer SA, Fucito LM. Evaluation of Web-Based and In-Person Methods to Recruit Adults With Type 1 Diabetes for a Mobile Exercise Intervention: Prospective Observational Study. JMIR Diabetes 2021, 6: e28309. PMID: 34047700, PMCID: PMC8299346, DOI: 10.2196/28309.Peer-Reviewed Original ResearchType 1 diabetesEligible volunteersExercise interventionClinical trialsIncremental costProspective observational studyGreater New HavenCharacteristics of enrolleesHigh-risk participantsOlder patientsOverall cohortPatients 18Clinical visitsUncommon conditionAdults 18Observational studySnowball samplingActive adultsT1DEligibility screeningPrior trialsLower click ratesPatientsActive individualsEligibility rates
2019
Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes
Danne T, Pettus J, Giaccari A, Cariou B, Rodbard H, Weinzimer S, Bonnemaire M, Sawhney S, Stewart J, Wang S, de Cassia Castro R, Garg S. Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes. Diabetes Technology & Therapeutics 2019, 21: 471-477. PMID: 31335194, PMCID: PMC6708262, DOI: 10.1089/dia.2019.0157.Peer-Reviewed Original ResearchConceptsSotagliflozin 200Insulin therapyHypoglycemia eventsRate of hypoglycemiaType 1 diabetesLevel 2 hypoglycemiaLower ratesImportant hypoglycemiaHypoglycemia ratesWeek 52Adult patientsGlycemic controlHypoglycemic eventsHypoglycemic rateClinical trialsInsulin treatmentPlaceboSotagliflozinHypoglycemiaType 1Phase 3PatientsTherapyWeeksAdults
2018
An Effective Diabetic Ketoacidosis Prevention Intervention in Children With Type 1 Diabetes
Vitale RJ, Card CE, Lichtman JH, Weyman K, Michaud C, Sikes K, Tamborlane WV, Weinzimer SA. An Effective Diabetic Ketoacidosis Prevention Intervention in Children With Type 1 Diabetes. SAGE Open Nursing 2018, 4: 2377960818804742. PMID: 33415207, PMCID: PMC7774356, DOI: 10.1177/2377960818804742.Peer-Reviewed Original ResearchSick-day managementEmergency department visitsDiabetic ketoacidosisDepartment visitsSymptoms of DKAEarly outpatient interventionEducational interventionShort educational interventionBrief refresher courseKnowledge of signsSame knowledge questionnaireParents of childrenTreatment modalitiesOutpatient interventionPrevention interventionsPatient recognitionKnowledge questionnaireType 1Sick daysEarly warning signsDay managementInterventionPatientsWarning signsSymptoms
2016
Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report
Maahs DM, Buckingham BA, Castle JR, Cinar A, Damiano ER, Dassau E, DeVries JH, Doyle FJ, Griffen SC, Haidar A, Heinemann L, Hovorka R, Jones TW, Kollman C, Kovatchev B, Levy BL, Nimri R, O’Neal D, Philip M, Renard E, Russell SJ, Weinzimer SA, Zisser H, Lum JW. Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report. Diabetes Care 2016, 39: 1175-1179. PMID: 27330126, PMCID: PMC4915553, DOI: 10.2337/dc15-2716.Peer-Reviewed Original Research
2013
Effectiveness of a Spanish Language Clinic for Hispanic Youth with Type 1 Diabetes
Palau-Collazo MM, Rose P, Sikes K, Kim G, Benavides V, Urban A, Weinzimer S, Tamborlane W. Effectiveness of a Spanish Language Clinic for Hispanic Youth with Type 1 Diabetes. Endocrine Practice 2013, 19: 800-804. PMID: 23757616, DOI: 10.4158/ep13004.or.Peer-Reviewed Original ResearchConceptsBody mass indexMean baseline glycated hemoglobin levelBaseline glycated hemoglobin levelHispanic pediatric patientsTarget HbA1c levelDuration of diabetesGlycated hemoglobin levelsType 1 diabetesHbA1c levelsPediatric patientsHemoglobin levelsHispanic patientsMass indexPatientsMetabolic controlType 1Pilot studyClinicDiabetesT1DLanguage clinicPreliminary findingsHispanic familiesHispanic youthGroup
2001
Acarbose treatment of postprandial hypoglycemia in children after Nissen fundoplication
Ng D, Ferry R, Kelly A, Weinzimer S, Stanley C, Katz L. Acarbose treatment of postprandial hypoglycemia in children after Nissen fundoplication. The Journal Of Pediatrics 2001, 139: 877-879. PMID: 11743518, DOI: 10.1067/mpd.2001.119169.Peer-Reviewed Original ResearchGraves' disease in patients with 22q11.2 deletion
Kawame H, Adachi M, Tachibana K, Kurosawa K, Ito F, Gleason M, Weinzimer S, Levitt-Katz L, Sullivan K, McDonald-McGinn D. Graves' disease in patients with 22q11.2 deletion. The Journal Of Pediatrics 2001, 139: 892-895. PMID: 11743521, DOI: 10.1067/mpd.2001.119448.Peer-Reviewed Original ResearchConceptsGraves' diseaseThyroid-stimulating hormone levelsSymptoms of hyperthyroidismMale patientsSerum levelsClinical presentationFemale patientsClinical spectrumFemale infantAge 27 monthsHormone levelsPatientsThyroid hormonesDiseaseDeletion syndromeHyperthyroidismSeizuresInfantsSyndromeSymptomsHormoneMonthsEndocrine aspects of the 22q11.2 deletion syndrome
Weinzimer S. Endocrine aspects of the 22q11.2 deletion syndrome. Genetics In Medicine 2001, 3: 19-22. PMID: 11339371, DOI: 10.1097/00125817-200101000-00005.Peer-Reviewed Original ResearchConceptsGrowth hormone deficiencyEndocrine disturbancesEndocrine disordersHormonal disordersAppropriate screeningHormone deficiencyEndocrine aspectsEndocrinological manifestationsPatientsDiGeorge syndromeDeletion syndromeSyndromeDisordersCurrent understandingHypoparathyroidismHyperthyroidismHypothyroidismDeletion
1998
Growth Hormone Deficiency in Patients With a 22q11.2 Deletion: Expanding the Phenotype
Weinzimer S, McDonald-McGinn D, Driscoll D, Emanuel B, Zackai E, Moshang T. Growth Hormone Deficiency in Patients With a 22q11.2 Deletion: Expanding the Phenotype. Pediatrics 1998, 101: 929-932. PMID: 9565428, DOI: 10.1542/peds.101.5.929.Peer-Reviewed Original ResearchConceptsGrowth hormone deficiencyShort statureCardiac anomaliesHormone deficiencyVelocardiofacial syndromeLike growth factor I axisProvocative growth hormone testingT-cell abnormalitiesGrowth hormone therapyGrowth hormone testingFinal height predictionConotruncal cardiac anomaliesThird of childrenConotruncal anomaly face syndromeMild facial dysmorphiaHormone therapyPituitary anatomyHormone testingPituitary abnormalitiesI axisThymic aplasiaCell abnormalitiesGeneral populationPatientsDiGeorge sequence
1997
A syndrome of congenital hyperinsulinism and hyperammonemia
Weinzimer S, Stanley C, Berry G, Yudkoff M, Tuchman M, Thornton P. A syndrome of congenital hyperinsulinism and hyperammonemia. The Journal Of Pediatrics 1997, 130: 661-664. PMID: 9108870, DOI: 10.1016/s0022-3476(97)70256-7.Peer-Reviewed Original ResearchConceptsCongenital hyperinsulinismLarge glycemic responseAcid levelsFree fatty acid levelsUrea cycle enzyme defectsElevated insulin levelsDiagnosis of hyperinsulinismUrinary amino acidsOrotic acid levelsUrinary orotic acid levelsAdministration of glucagonFatty acid levelsAutosomal recessive variantInsulin levelsBenzoate therapyProtein restrictionInsulin secretionUnusual syndromeUrinary organic acidsHyperammonemic disordersGlycemic responseHyperinsulinismPatientsProtein feedingRecessive variantsThe 22q11.2 Deletion: Screening, Diagnostic Workup, and Outcome of Results; Report on 181 Patients
McDonald-McGinn DM, LaRossa D, Goldmuntz E, Sullivan K, Eicher P, Gerdes M, Moss E, Wang P, Solot C, Schultz P, Lynch D, Bingham P, Keenan G, Weinzimer S, Ming JE, Driscoll D, Clark BJ, Markowitz R, Cohen A, Moshang T, Pasquariello P, Randall P, Emanuel BS, Zackai EH. The 22q11.2 Deletion: Screening, Diagnostic Workup, and Outcome of Results; Report on 181 Patients. Genetic Testing And Molecular Biomarkers 1997, 1: 99-108. PMID: 10464633, DOI: 10.1089/gte.1997.1.99.Peer-Reviewed Original ResearchConceptsCayler cardiofacial syndromeCohort of patientsMajority of patientsConotruncal cardiac anomaliesConotruncal anomaly face syndromeSubmicroscopic deletionCardiac anomaliesDiagnostic workupCardiofacial syndromeOpitz G/BBB syndromePatientsSyndromeDiGeorge syndromeFace syndromeVelocardiofacial syndromeVariable phenotypeBBB syndromeChromosome 22q11.2Outcome of resultsDeletionCohortSubspecialistsWorkupClinicians